These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 37480469)
1. Critical thinking of Alzheimer's transgenic mouse model: current research and future perspective. Li X; Quan M; Wei Y; Wang W; Xu L; Wang Q; Jia J Sci China Life Sci; 2023 Dec; 66(12):2711-2754. PubMed ID: 37480469 [TBL] [Abstract][Full Text] [Related]
2. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis. Crews L; Rockenstein E; Masliah E Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183 [TBL] [Abstract][Full Text] [Related]
3. Staining and Quantification of β-Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease. Christensen A; Pike CJ Methods Mol Biol; 2020; 2144():211-221. PubMed ID: 32410038 [TBL] [Abstract][Full Text] [Related]
4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]
5. Mouse models of Alzheimer's disease for preclinical research. Watamura N; Sato K; Saido TC Neurochem Int; 2022 Sep; 158():105361. PubMed ID: 35618239 [TBL] [Abstract][Full Text] [Related]
6. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis. Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565 [TBL] [Abstract][Full Text] [Related]
7. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure. Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478 [TBL] [Abstract][Full Text] [Related]
8. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868 [TBL] [Abstract][Full Text] [Related]
9. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models. Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942 [TBL] [Abstract][Full Text] [Related]
10. Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor. Pu YZ; Liang L; Fu AL; Liu Y; Sun L; Li Q; Wu D; Sun MJ; Zhang YG; Zhao BQ Curr Alzheimer Res; 2017; 14(6):668-679. PubMed ID: 27978793 [TBL] [Abstract][Full Text] [Related]
11. PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease. Dumont M; Stack C; Elipenahli C; Jainuddin S; Launay N; Gerges M; Starkova N; Starkov AA; Calingasan NY; Tampellini D; Pujol A; Beal MF FASEB J; 2014 Apr; 28(4):1745-55. PubMed ID: 24398293 [TBL] [Abstract][Full Text] [Related]
12. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology. Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769 [TBL] [Abstract][Full Text] [Related]
13. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain. Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021 [TBL] [Abstract][Full Text] [Related]
14. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease. Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948 [TBL] [Abstract][Full Text] [Related]
15. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice. Devi L; Ohno M Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558 [TBL] [Abstract][Full Text] [Related]
16. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics. Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754 [TBL] [Abstract][Full Text] [Related]
17. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease. Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117 [TBL] [Abstract][Full Text] [Related]